- トップページ >
- トピックス
Session Info: Meet the Professor Seminar, [MP604] DOES EARLY INTERVENTION BENEFIT PATIENTS WITH LAM?
Learning Objective 1: be able to understand cellular and molecular mechanisms and clinical features of
lymphangioleiomyomatosis
Learning Objective 2: learn how effective it will be in practice when the patients with LAM are treated with sirolimus
Learning Objective 3: learn when and what kinds of adverse effects you should take care in the treatment
Day/Date: Tuesday, May 19, 2015
Session Time: 12:15 PM - 1:15 PM
Room: Mineral Hall D (Third Floor)
Location: Hyatt Regency Denver at CCC
Speakers: K. Nakata, MD, PhD, T. Takada, MD, PhD
Niigata/JP
